A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children (original) (raw)
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults
Lars Rosengren
Journal of Neuroscience Methods, 1994
View PDFchevron_right
Evaluation of serum Neuron-specific enolase, S100B, myelin basic protein and glial fibrilliary acidic protein as brain specific proteins in children with autism spectrum disorder
Erman Esnafoglu
International Journal of Developmental Neuroscience, 2017
View PDFchevron_right
Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders
Anders Wallin
Biological Psychiatry, 1993
View PDFchevron_right
Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
Helmuth Steinmetz
PLoS ONE, 2013
View PDFchevron_right
An ELISA for glial fibrillary acidic protein
Gavin Giovannoni
Journal of Immunological Methods, 2004
View PDFchevron_right
Measurement of glial fibrillary acidic protein (GFAP) and anti-GFAP antibodies by solid-phase radioimmunoassays
Juhani Ruutiainen
Acta Neurologica Scandinavica, 2009
View PDFchevron_right
Plasma Levels of Glial Cell Marker S100B in Children With Autism
Aleksandra Tomova
Physiological Research, 2019
View PDFchevron_right
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Hayrettin Tumani
Nature Reviews Neurology, 2022
View PDFchevron_right
Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)
Roopa Ghirnikar
Neurochemical Research, 2000
View PDFchevron_right
Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker
Kevin K.W. Wang
Trends in neurosciences, 2015
View PDFchevron_right
Measurement of glial fibrillary acidic protein by a two-site immunoradiometric assay
Lim Eng
Analytical Biochemistry, 1976
View PDFchevron_right
Role of glial fibrillary acidic protein (GFAP) marker in central nervous system lesions
IP Innovative Publication Pvt. Ltd.
IP Innovative Publication Pvt. Ltd., 2017
View PDFchevron_right
Elevated GFAP Protein in Anterior Cingulate Cortical White Matter in Males With Autism Spectrum Disorder
G. Ordway
Autism research : official journal of the International Society for Autism Research, 2015
View PDFchevron_right
Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies
waney squier
Neuropathology and Applied Neurobiology, 2009
View PDFchevron_right
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
Marta Milà Alomà
JAMA Neurology
View PDFchevron_right
A simple, sensitive and widely applicable ELISA for S100B: Methodological features of the measurement of this glial protein
Rodrigo Freitas
Journal of Neuroscience Methods, 2008
View PDFchevron_right
High Serum Levels of Serum 100 Beta Protein, Neuron-specific Enolase, Tau, Active Caspase-3, M30 and M65 in Children with Autism Spectrum Disorders
Ismail Akaltun
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2020
View PDFchevron_right
Diagnostic value of serum glial fibrillary acidic protein and S100B serum levels in emergency medicine patients with traumatic versus nontraumatic intracerebral hemorrhage
onder yumrutas
Nigerian Journal of Clinical Practice
View PDFchevron_right
Identification of a human glial fibrillary acidic protein cDNA: A tool for the molecular analysis of reactive gliosis in the mammalian central nervous system
Nicole Biguet
Journal of Neuroscience Research, 1988
View PDFchevron_right
Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury
carlos barron
Alzheimer's Research & Therapy, 2021
View PDFchevron_right
Quantification of neurodegeneration by measurement of brain-specific proteins
Gavin Giovannoni
Journal of Neuroimmunology, 2003
View PDFchevron_right
GFAP and S100B in the acute phase of mild traumatic brain injury
Joukje van der Naalt
Neurology, 2012
View PDFchevron_right
NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries
ahmet güneyk
Clinical Neurology and Neurosurgery, 2019
View PDFchevron_right
Reference ranges for neuroprotein S-100B: from infants to adolescents
Wolfgang Erwa
Clinical Chemistry and Laboratory Medicine, 2008
View PDFchevron_right
Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system
Milos Pekny
Current Opinion in Cell Biology, 2015
View PDFchevron_right
Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury
Aarti Chawla
Biomarker Insights, 2012
View PDFchevron_right
CSF and Blood Levels of GFAP in Alexander Disease
W Benko
eNeuro, 2015
View PDFchevron_right